Pacific Biosciences of California, Inc. (PACB)
1.835
+0.10
(+6.07%)
USD |
NASDAQ |
Oct 19, 16:00
1.835
0.00 (0.00%)
After-Hours: 16:48
Pacific Biosciences of California Cash from Operations (Annual) : -111.21M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -111.21M |
| December 31, 2024 | -206.06M |
| December 31, 2023 | -266.55M |
| December 31, 2022 | -263.21M |
| December 31, 2021 | -111.18M |
| December 31, 2020 | 19.50M |
| December 31, 2019 | -78.31M |
| December 31, 2018 | -66.43M |
| December 31, 2017 | -67.52M |
| December 31, 2016 | -67.93M |
| Date | Value |
|---|---|
| December 31, 2015 | -47.89M |
| December 31, 2014 | -51.47M |
| December 31, 2013 | -29.83M |
| December 31, 2012 | -76.82M |
| December 31, 2011 | -102.97M |
| December 31, 2010 | -122.00M |
| December 31, 2009 | -74.84M |
| December 31, 2008 | -38.30M |
| December 31, 2007 | -16.73M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Illumina, Inc. | 1.079B |
| Danaher Corp. | 6.416B |
| Thermo Fisher Scientific, Inc. | 7.818B |
| Agilent Technologies, Inc. | 1.559B |
| Bio-Rad Laboratories, Inc. | 532.20M |